Clinical Trial Update: Urinary Neutrophil Gelatinase-Associated Lipocalin (uNGAL) in Invasive Cardiology

View source ↗

Summary

A completed clinical trial evaluating urinary NGAL as a biomarker in invasive cardiology for patients with renal failure. The study (NCT01612117) was conducted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Snippet

Sponsor: University of Freiburg | Conditions: Renal Failure | Status: COMPLETED